Valley Medical Pharmacy 
630 Main Street 
Brawley, CA 92227 
eRx ID#0585957 
1 (800) 322-0808 | Toll Free Fax: 1 (855) 322-0808 
Email: drugsdepot@yahoo.com 
Web: www.drugsdepot 
Timing: Monday to Friday | 9:00 AM to 5:45 PM 


Menu

Azor 10-40 Mg Tabs 90 By Daiichi Sankyo Pharma.

Image 0 of Azor 10-40 Mg Tabs 90 By Daiichi Sankyo Pharma.Image 1 of Azor 10-40 Mg Tabs 90 By Daiichi Sankyo Pharma.

Azor 10-40 Mg Tabs 90 By Daiichi Sankyo Pharma.

Call for Price

Azor 10-40 Mg Tabs 90 By Daiichi Sankyo Pharma. This Item Requires A Valid Order From A Physician Licensed in USA. Item Number.:RXD4022190/RXB10043539/RXa011338/RXA322127
Size : 90
Selling UoM : EA
NDC: 65597-0113-90
UPC Barcode :365597113909
Supplier: 0050000874 DAIICHI SANKYO
Supplier Material : 011390
Generic Code : 063182 AMLODIPINE BES/OLMESARTAN MED ORAL TABLE
Fine Line Class : 850085008510 All Rx Products
Product Category : RX Pharmaceuticals
Product Type : BRX

Have a question?

  Call for Price

Product Description.:

C77
tablet , red , round round

AZOR is a prescription drug used for the treatment of hypertension or high blood pressure. AZOR contains two different active ingredients in one tablet, namely amlodipine and olmesartan medoxomil.

AZOR may be used either alone or in combination with other drugs to treat high blood pressure.

AZOR is not indicated for initial blood pressure therapy.

AZOR should not be used during pregnancy.

Be sure to tell your healthcare provider if you are trying to become pregnant, are already pregnant, or are breast-feeding.

It is particularly important to tell your healthcare provider if you are currently taking diuretics (water pills) because starting AZOR therapy in some patients taking diuretics or who may have low salt or fluid levels may increase the possibility of hypotension (low blood pressure) that may require treatment.

Tell your healthcare provider if you have any heart problems, such as severe aortic stenosis (narrowing of the aortic valve), coronary artery disease, or congestive heart failure.

Tell your healthcare provider if you have kidney or liver problems. While no initial dosage adjustments for AZOR are usually necessary for patients with kidney or liver problems, nor in those who are elderly, your healthcare provider may want to monitor you more closely.

If you are taking any other prescription or nonprescription medicines, including vitamins and herbal supplements, tell your healthcare provider. This information can help your healthcare provider avoid possible interactions with AZOR. If you decide to stop taking AZOR for any reason, you should notify your healthcare provider as soon as possible.

The most common side effect with AZOR was edema. In the clinical study, only edema occurred in greater than or equal to 3% of patients treated with AZOR and more frequently than placebo. The placebo-subtracted incidence was 5.7% with AZOR 5/20 mg, 6.2% with AZOR 5/40 mg, 13.3% with AZOR 10/20 mg, and 11.2% with AZOR 10/40 mg. The edema incidence for placebo was 12.3%. A placebo is an inactive, nondrug substance, such as a sugar pill, that is given in a drug study to compare the effect of a treatment including the drug being studied with the effect of the same treatment without the drug. Placebo-subtracted incidence means subtracting the percent of patients who took placebo and had edema from the total percent of patients who had edema for each other dose.

Other side effects occurred less often than edema but at about the same or greater frequency as in patients receiving placebo. These side effects included low blood pressure, low blood pressure after standing up too quickly, rash, itching, heart palpitation, urinating more often, and excessive urination throughout the night.

In separate clinical studies of the individual components of AZOR, other common side effects included headache, dizziness, and flushing. Call your healthcare provider if you experience any unpleasant effects while taking AZOR.

The content provided herein is for informational purposes only and does not constitute or substitute for professional medical advice, diagnosis, or treatment. Talk to your doctor for more information about your specific condition.

USE IN PREGNANCY

When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus. When pregnancy is detected, AZOR should be discontinued as soon as possible.

Click here for Prescribing Information